Botulinum Neurotoxins and Botulism: A Novel Therapeutic Approach

Specific treatment is not available for human botulism. Current remedial mainstay is the passive administration of polyclonal antibody to botulinum neurotoxin (BoNT) derived from heterologous species (immunized animal or mouse hybridoma) together with supportive and symptomatic management. The antib...

Descripción completa

Detalles Bibliográficos
Autores principales: Thanongsaksrikul, Jeeraphong, Chaicumpa, Wanpen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2011
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3202833/
https://www.ncbi.nlm.nih.gov/pubmed/22069720
http://dx.doi.org/10.3390/toxins3050469

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3202833/
https://www.ncbi.nlm.nih.gov/pubmed/22069720
http://dx.doi.org/10.3390/toxins3050469

Ejemplares similares